- not yet recruitingNA
Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis
This study looks at a smartphone app to help people with types of arthritis like rheumatoid arthritis. It checks if the app helps them manage their medicines safely and understand their condition better.
France - recruiting
AYLo - AutoimmunitY and Loss of y
This study looks at how changes in your `Y` chromosome, which only men have, might be linked to certain long-term conditions like arthritis and similar diseases. Researchers want to understand if these changes affect how your immune system works and the progression of these conditions.
Germany - not yet recruitingNA
Personalized Outreach for Equitable Treatment in Rheumatology
This study looks at how we can help people with rheumatic diseases attend their clinic appointments in Vancouver. We're testing if offering a small payment or extra personal support can make a difference in helping people get the care they need.
Canada - active not recruitingPHASE3
A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
This study is testing a new medicine, risankizumab, for adults with active psoriatic arthritis, especially those who haven't responded well to other treatments. It aims to see how safe and effective it is in reducing symptoms.
United States · Argentina · Australia - authorisedTherapeutic confirmatory (Phase III)
Clinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-groups, randomised controlled trial
This study looks at how well a medicine called Taltz (ixekizumab) works for adults with a type of arthritis called psoriatic arthritis, specifically when it affects fingers and toes. We're comparing it to another medication, Metoject (methotrexate), to see which one helps more with swelling and pain.
Italy - recruiting
Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
This study looks at how well certain new treatments work for people with types of arthritis called axial spondyloarthritis (axSpA) or psoriatic arthritis (PsA). It gathers information from medical records and patient surveys to understand treatment effectiveness from different viewpoints.
United Kingdom - authorisedTherapeutic confirmatory (Phase III)
A Phase 3, multicenter, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
This study looks at a new medicine called sonelokimab for psoriatic arthritis. It checks how safe and helpful the medicine is over a long time for people who have already tried it in another study. Doctors will monitor side effects and overall health.
Estonia · Croatia · Slovakia - recruitingNA
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
This study looks at how weight loss (using a medication called tirzepatide) or treatment with iksekizumab affects people with psoriatic arthritis who are also overweight or obese. It checks changes in their skin, joints, and fat.
United Kingdom